{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:38:54Z","timestamp":1792532334941,"version":"4.5.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the incidence of retinal pigment epithelium (RPE) remodeling after RPE tears in age-related macular degeneration and assess its association with visual outcomes over a 5-year follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective observational study reviewed age-related macular degeneration eyes with RPE tears and a minimum follow-up of 5 years. Changes in best-corrected visual acuity (BCVA) were recorded, and the presence and delay to development of tear-associated retinal pigment epithelial proliferation were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twenty-six eyes from 23 patients were included. The mean age was 80.08 \u00b1 6.67 years. Baseline BCVA was 0.83 \u00b1 0.52 logMAR (Snellen equivalent 20\/125), and final BCVA declined to 1.05 \u00b1 0.54 logMAR (20\/200) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.028). The mean follow-up was 6.25 \u00b1 1.25 years. Both the greatest linear diameter and the area of RPE loss increased significantly from baseline to Year 5 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.012 and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.009, respectively). Tear-associated retinal pigment epithelial proliferation was observed in 54.2% of eyes at 5 years, with a mean onset of 293 \u00b1 258 days. Final BCVA was significantly worse in eyes with subretinal hemorrhage (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02), while the presence of tear-associated retinal pigment epithelial proliferation was not associated with visual outcome (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.21). At 5 years, BCVA declined in both groups (with and without tear-associated retinal pigment epithelial proliferation), with no significant difference (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.21).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Approximately half of the eyes with RPE tears developed tear-associated retinal pigment epithelial proliferation, typically within the first year. Tear-associated retinal pigment epithelial proliferation did not confer a visual benefit. These findings suggest that anatomical remodeling of RPE tears may occur without translating into improved visual outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004960","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T21:00:26Z","timestamp":1786136426000},"page":"1910-1916","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["OUTCOMES AND HEALING PROCESS OF RETINAL PIGMENT EPITHELIAL TEARS IN PATIENTS WITH AMD"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8260-4323","authenticated-orcid":false,"given":"Hela","family":"Sassi","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Cr\u00e9teil, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Miere","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Cr\u00e9teil, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassiba","family":"Oubraham","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Cr\u00e9teil, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desire","family":"Kaoudio","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Centre Hospitalier Intercommunal de Cr\u00e9teil, Cr\u00e9teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Ionita","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Cr\u00e9teil, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meryem","family":"El Filali","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Cr\u00e9teil, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Bourroubey","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Cr\u00e9teil, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Centre Hospitalier Intercommunal de Cr\u00e9teil, Cr\u00e9teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Jung","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Centre Hospitalier Intercommunal de Cr\u00e9teil, Cr\u00e9teil, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Souied","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Centre Hospitalier Intercommunal de Cr\u00e9teil, Universit\u00e9 Paris Est Cr\u00e9teil, Cr\u00e9teil, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/IAE.0b013e3180a032db","article-title":"Tears of the retinal pigment epithelium: an old problem in a new era","volume":"27","author":"Chang","year":"2007","journal-title":"Retina"},{"key":"R2-20261020","first-page":"142","article-title":"Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis)","volume":"112","author":"Sarraf","year":"2014","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R3-20261020","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/IAE.0000000000000823","article-title":"Retinal pigment epithelial tear and anti-vascular endothelial growth factor therapy in exudative age-related macular degeneration: clinical course and long-term prognosis","volume":"36","author":"Heimes","year":"2016","journal-title":"Retina"},{"key":"R4-20261020","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/IAE.0b013e31828992f5","article-title":"Prospective evaluation of the incidence and risk factors for the development of rpe tears after high- and low-dose ranibizumab therapy","volume":"33","author":"Sarraf","year":"2013","journal-title":"Retina"},{"key":"R5-20261020","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1097\/IAE.0000000000000056","article-title":"Pigment epithelial tears associated with anti-vegf therapy: incidence, long-term visual outcome, and relationship with pigment epithelial detachment in Age-related macular degeneration","volume":"34","author":"Doguizi","year":"2014","journal-title":"Retina"},{"key":"R6-20261020","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ajo.2006.07.037","article-title":"Retinal pigment epithelial tear after intravitreal bevacizumab injection","volume":"142","author":"Shah","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R7-20261020","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/IAE.0000000000002029","article-title":"Incidence and long-term visual acuity outcomes of retinal pigment epithelium tears after intravitreal anti\u2013vascular endothelial growth factor treatment of neovascular age-related macular degeneration","volume":"39","author":"Vazquez-Alfageme","year":"2019","journal-title":"Retina"},{"key":"R8-20261020","doi-asserted-by":"crossref","first-page":"NP100","DOI":"10.1177\/11206721221093025","article-title":"Sequential retinal pigment epithelium tears following intravitreal ranibizumab injections for age-related macular degeneration","volume":"33","author":"Venkatesh","year":"2023","journal-title":"Eur J Ophthalmol"},{"key":"R9-20261020","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.2147\/OPTH.S47735","article-title":"Retinal pigment epithelium tear after intravitreal aflibercept injection","volume":"7","author":"Saito","year":"2013","journal-title":"Clin Ophthalmol (Auckland, N.Z.)"},{"key":"R10-20261020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000529930","article-title":"Old problem in a new guise: retinal pigment epithelium tear after intravitreal faricimab (Vabysmo) injection","volume":"14","author":"Clemens","year":"2023","journal-title":"Case Rep Ophthalmol"},{"key":"R11-20261020","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/IAE.0000000000001009","article-title":"Retinal pigment epithelial tear after intravitreal ranibizumab treatment for neovascular age-related macular degeneration","volume":"36","author":"Cho","year":"2016","journal-title":"Retina"},{"key":"R12-20261020","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ajo.2013.06.024","article-title":"Mechanism of retinal pigment epithelium tear formation following intravitreal anti\u2013vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography","volume":"156","author":"Nagiel","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"R13-20261020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/IAE.0000000000003332","article-title":"Clinical associations and prognostic implications of repair tissue proliferation in eyes with retinal pigment epithelium tears","volume":"42","author":"Cicinelli","year":"2022","journal-title":"Retina"},{"key":"R14-20261020","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1097\/IAE.0000000000001062","article-title":"Double retinal pigment epithelium tears in neovascular age-related macular degeneration","volume":"36","author":"Mouallem","year":"2016","journal-title":"Retina"},{"key":"R15-20261020","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/IAE.0b013e3181cdf366","article-title":"A new grading system for retinal pigment epithelial tears","volume":"30","author":"Sarraf","year":"2010","journal-title":"Retina"},{"key":"R16-20261020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3928\/23258160-20170829-04","article-title":"Centrifugal extension of retinal atrophy in retinal pigment epithelium tears secondary to age-related macular degeneration","volume":"48","author":"Capuano","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R17-20261020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1055\/a-2248-9986","article-title":"Long-term Follow-Up and regeneration of retinal pigment epithelium (RPE) after tears of the epithelium in exudative age-related macular degeneration (AMD)","volume":"241","author":"Skalicky","year":"2024","journal-title":"Klin Monbl Augenheilkd"},{"key":"R18-20261020","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1038\/s41598-025-88128-8","article-title":"Assessment of retinal pigment epithelium tears in eyes with submacular hemorrhage secondary to age-related macular degeneration","volume":"15","author":"Ueda-Consolvo","year":"2025","journal-title":"Sci Rep"},{"key":"R19-20261020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/IAE.0000000000003083","article-title":"Management of retinal pigment epithelium tear during anti\u2013vascular endothelial growth factor therapy","volume":"41","author":"Mitchell","year":"2021","journal-title":"Retina"},{"key":"R20-20261020","first-page":"1","article-title":"Intravitreal anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration and retinal pigment epithelial tear: a systematic review and meta-analysis","author":"Mavridou","year":"2025","journal-title":"Semin Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004960","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:00:13Z","timestamp":1792530013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004960"}},"subtitle":["A 5-Year Retrospective Observational Case Series"],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004960","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11]]}}}